UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Benralizumab: From the Basic Mechanism of Action to the Potential Use in the Biological Therapy of Severe Eosinophilic Asthma

BioMed research international, 2018-01, Vol.2018, p.4839230-9

2018

Volltextzugriff (PDF)

Cellular Mechanisms Underlying Eosinophilic and Neutrophilic Airway Inflammation in Asthma

Mediators of Inflammation, 2015-01, Vol.2015 (1), p.879783-879783

2015

Volltextzugriff (PDF)

Real-Life effects of benralizumab on exacerbation number and lung hyperinflation in atopic patients with severe eosinophilic asthma

Biomedicine & pharmacotherapy, 2020-09, Vol.129, p.110444, Article 110444

2020

Volltextzugriff (PDF)

New treatments for asthma: From the pathogenic role of prostaglandin D2 to the therapeutic effects of fevipiprant

Pharmacological research, 2020-05, Vol.155, p.104490-104490, Article 104490

2020

Volltextzugriff (PDF)

Real-life effects of dupilumab in patients with severe type 2 asthma, according to atopic trait and presence of chronic rhinosinusitis with nasal polyps

Frontiers in immunology, 2023-03, Vol.14, p.1121237-1121237

2023

Volltextzugriff (PDF)

Severe eosinophilic asthma: from the pathogenic role of interleukin-5 to the therapeutic action of mepolizumab

Drug design, development and therapy, 2017-01, Vol.11, p.3137-3144

2017

Volltextzugriff (PDF)

Anti-IgE therapy with omalizumab for severe asthma: current concepts and potential developments

Current drug targets, 2015-01, Vol.16 (2), p.171-178

2015

Volltextzugriff (PDF)

Oxygen therapy via high flow nasal cannula in severe respiratory failure caused by Sars-Cov-2 infection: a real-life observational study

Therapeutic advances in respiratory disease, 2020, Vol.14, p.1753466620963016-1753466620963016

2020

Volltextzugriff (PDF)

Effects of the first three doses of benralizumab on symptom control, lung function, blood eosinophils, oral corticosteroid intake, and nasal polyps in a patient with severe allergic asthma

SAGE open medical case reports, 2020, Vol.8, p.2050313X20906963

2020

Volltextzugriff (PDF)

Molecular mechanisms underlying airway smooth muscle contraction and proliferation: Implications for asthma

Respiratory medicine, 2008-08, Vol.102 (8), p.1173-1181

2008

Volltextzugriff (PDF)

Real-life evaluation of the clinical, functional, and hematological effects of mepolizumab in patients with severe eosinophilic asthma: Results of a single-centre observational study

Pulmonary pharmacology & therapeutics, 2018-12, Vol.53, p.1-5

2018

Volltextzugriff (PDF)

Real-life rapidity of benralizumab effects in patients with severe allergic eosinophilic asthma: Assessment of blood eosinophils, symptom control, lung function and oral corticosteroid intake after the first drug dose

Pulmonary pharmacology & therapeutics, 2019-10, Vol.58, p.101830-101830, Article 101830

2019

Volltextzugriff (PDF)

New treatments for asthma: From the pathogenic role of prostaglandin D 2 to the therapeutic effects of fevipiprant

Pharmacological research, 2020-05, Vol.155, p.104490

2020

Volltextzugriff (PDF)

Review: Omalizumab in the treatment of severe asthma: efficacy and current problems

Therapeutic Advances in Respiratory Disease, 2008-12, Vol.2 (6), p.409-421

2008

Volltextzugriff (PDF)

Clinical characteristics and predictors of mortality associated with COVID-19 in elderly patients from a long-term care facility

Scientific reports, 2020-11, Vol.10 (1), p.20834, Article 20834

2020

Volltextzugriff (PDF)

Molecular and cellular mechanisms underlying the therapeutic effects of budesonide in asthma

Pulmonary pharmacology & therapeutics, 2016-10, Vol.40, p.15-21

2016

Volltextzugriff (PDF)

Omalizumab lowers asthma exacerbations, oral corticosteroid intake and blood eosinophils: Results of a 5-YEAR single-centre observational study

Pulmonary pharmacology & therapeutics, 2019-02, Vol.54, p.25-30

2019

Volltextzugriff (PDF)

Short-Term Evaluation of Dupilumab Effects in Patients with Severe Asthma and Nasal Polyposis

Journal of asthma and allergy, 2021-01, Vol.14, p.1165-1172

2021

Volltextzugriff (PDF)

Update on Anticytokine Treatment for Asthma

BioMed research international, 2013-01, Vol.2013, p.104315-10

2013

Volltextzugriff (PDF)

Role of biologics in severe eosinophilic asthma - focus on reslizumab

Therapeutics and clinical risk management, 2016-01, Vol.12, p.1075-1082

2016

Volltextzugriff (PDF)

Application of Proteomics and Peptidomics to COPD

BioMed research international, 2014-01, Vol.2014, p.764581-8

2014

Volltextzugriff (PDF)

Long-Term Clinical and Sustained REMIssion in Severe Eosinophilic Asthma treated with Mepolizumab: The REMI-M study

The journal of allergy and clinical immunology in practice (Cambridge, MA), 2024-08

2024

Volltextzugriff (PDF)

Late-onset myocardial infarction and autoimmune haemolytic anaemia in a COVID-19 patient without respiratory symptoms, concomitant with a paradoxical increase in inflammatory markers: a case report

Journal of medical case reports, 2020-12, Vol.14 (1), p.246-246, Article 246

2020

Volltextzugriff (PDF)

A case report of pneumomediastinum in a COVID‐19 patient treated with high‐flow nasal cannula and review of the literature: Is this a “spontaneous” complication?

Clinical case reports, 2021-05, Vol.9 (5), p.n/a

2021

Volltextzugriff (PDF)

Pharmacologic rationale underlying the therapeutic effects of tiotropium/olodaterol in COPD

Therapeutics and clinical risk management, 2015-01, Vol.11 (default), p.1563-1572

2015

Volltextzugriff (PDF)

1 – 25 von 30

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(29)
Mit Volltextzugriff
(28)

Publikationsform

Artikel
(29)
Berichte
(1)

Sprache

Englisch
(30)
Japanisch
(6)

Erscheinungsjahr

n.n

Thema

Science & Technology
(25)
Life Sciences & Biomedicine
(24)
Humans
(16)
Asthma
(10)
Asthma - Drug Therapy
(10)
Pharmacology & Pharmacy
(8)
Respiratory System
(8)
Review
(8)
Severe Asthma
(8)
Animals
(6)
Anti-Asthmatic Agents - Therapeutic Use
(6)
Asthma - Immunology
(6)
Health Aspects
(6)
Inflammation
(6)
Monoclonal Antibodies
(6)
Asthma - Physiopathology
(5)
Cytokines
(5)
Female
(5)
Immunology
(5)
Immunotherapy
(5)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Benralizumab: From the Basic Mechanism of Action to the Potential Use in the Biological Therapy of Severe Eosinophilic Asthma

Cellular Mechanisms Underlying Eosinophilic and Neutrophilic Airway Inflammation in Asthma

Real-Life effects of benralizumab on exacerbation number and lung hyperinflation in atopic patients with severe eosinophilic asthma

New treatments for asthma: From the pathogenic role of prostaglandin D2 to the therapeutic effects of fevipiprant

Real-life effects of dupilumab in patients with severe type 2 asthma, according to atopic trait and presence of chronic rhinosinusitis with nasal polyps

Severe eosinophilic asthma: from the pathogenic role of interleukin-5 to the therapeutic action of mepolizumab

Anti-IgE therapy with omalizumab for severe asthma: current concepts and potential developments

Oxygen therapy via high flow nasal cannula in severe respiratory failure caused by Sars-Cov-2 infection: a real-life observational study

Effects of the first three doses of benralizumab on symptom control, lung function, blood eosinophils, oral corticosteroid intake, and nasal polyps in a patient with severe allergic asthma

Molecular mechanisms underlying airway smooth muscle contraction and proliferation: Implications for asthma

Real-life evaluation of the clinical, functional, and hematological effects of mepolizumab in patients with severe eosinophilic asthma: Results of a single-centre observational study

Real-life rapidity of benralizumab effects in patients with severe allergic eosinophilic asthma: Assessment of blood eosinophils, symptom control, lung function and oral corticosteroid intake after the first drug dose

New treatments for asthma: From the pathogenic role of prostaglandin D 2 to the therapeutic effects of fevipiprant

Review: Omalizumab in the treatment of severe asthma: efficacy and current problems

Clinical characteristics and predictors of mortality associated with COVID-19 in elderly patients from a long-term care facility

Molecular and cellular mechanisms underlying the therapeutic effects of budesonide in asthma

Omalizumab lowers asthma exacerbations, oral corticosteroid intake and blood eosinophils: Results of a 5-YEAR single-centre observational study

Short-Term Evaluation of Dupilumab Effects in Patients with Severe Asthma and Nasal Polyposis

Update on Anticytokine Treatment for Asthma

Role of biologics in severe eosinophilic asthma - focus on reslizumab

Application of Proteomics and Peptidomics to COPD

Long-Term Clinical and Sustained REMIssion in Severe Eosinophilic Asthma treated with Mepolizumab: The REMI-M study

Late-onset myocardial infarction and autoimmune haemolytic anaemia in a COVID-19 patient without respiratory symptoms, concomitant with a paradoxical increase in inflammatory markers: a case report

A case report of pneumomediastinum in a COVID‐19 patient treated with high‐flow nasal cannula and review of the literature: Is this a “spontaneous” complication?

Pharmacologic rationale underlying the therapeutic effects of tiotropium/olodaterol in COPD

Suchergebnisse filtern